Roche Names New CEO for Roche Pharmaceuticals
December 10 2018 - 1:50AM
Dow Jones News
By Cristina Roca
Roche Holding AG (ROG.EB) said Monday that the chief executive
of its Roche Pharmaceuticals business is leaving at the end of the
year, and named his successor.
The Swiss pharmaceuticals company said current CEO Daniel O'Day
will step down as of Dec. 31, and said it was appointing William
Anderson to the post effective Jan. 1.
Roche said Mr. Anderson will also become a member of its
corporate executive committee.
Mr. Anderson is currently chief executive of Genentech, a Roche
subsidiary company. He has worked for Roche since 2006.
Separately, Roche said it was proposing Hans Clevers for
election to its board of directors. Mr. Clevers is a professor of
molecular genetics at University Medical Center Utrecht, the
company said.
Write to Cristina Roca at cristina.roca@dowjones.com;
@_cristinaroca
(END) Dow Jones Newswires
December 10, 2018 01:35 ET (06:35 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Sep 2023 to Sep 2024